Aptose Biosciences (APTO) Misses Q2 EPS by 215c
Tweet
Share
E-mailGet Alerts APTO Hot Sheet
Join SI Premium – FREE
Aptose Biosciences (NASDAQ: APTO) reported Q2 EPS of ($2.27), $2.15 worse than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Aptose Biosciences (APTO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- InspireMD (NSPR) Tops Q2 EPS by 1c
- Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
